Further exploration of native cells will demand the development of tools, such as highly-sensitive antibodies, with potential utility as biomarkers of PINK1/Parkin pathway activity and that enable the quantitative monitoring of this signalling pathway in PD patients. Here, PINK1 is linked to Parkinson disease.